{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:57:42Z","timestamp":1792421862210,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since the emergence of the Omicron variants at the end of 2021, they quickly became the dominant variants globally. The Omicron variants may be more easily transmitted compared to the earlier Wuhan and the other variants. In this study, we aimed to elucidate mechanisms of the altered infectivity associated with the Omicron variants. We systemically evaluated mutations located in the S2 sequence of spike and identified mutations that are responsible for altered viral fusion. We demonstrated that mutations near the S1\/S2 cleavage site decrease S1\/S2 cleavage, resulting in reduced fusogenicity. Mutations in the HR1 and other S2 sequences also affect cell-cell fusion. Based on nuclear magnetic resonance (NMR) studies and in silico modeling, these mutations affect fusogenicity possibly at multiple steps of the viral fusion. Our findings reveal that the Omicron variants have accumulated mutations that contribute to reduced syncytial formation and hence an attenuated pathogenicity.<\/jats:p>","DOI":"10.1038\/s42003-023-04923-x","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T07:02:07Z","timestamp":1684911727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2834-9071","authenticated-orcid":false,"given":"Seung Bum","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2113-1021","authenticated-orcid":false,"given":"Sai Chaitanya","family":"Chiliveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parker","family":"Irvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Leek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailis","family":"Grieshaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-702X","authenticated-orcid":false,"given":"T. Jake","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"4923_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2022","unstructured":"Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602, 654\u2013656 (2022).","journal-title":"Nature"},{"key":"4923_CR2","unstructured":"World Health Organization. Tracking SARS-CoV-2 variants. https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants (2022)."},{"key":"4923_CR3","doi-asserted-by":"publisher","first-page":"110770","DOI":"10.1016\/j.celrep.2022.110770","volume":"39","author":"H Guo","year":"2022","unstructured":"Guo, H. et al. Structures of Omicron spike complexes and implications for neutralizing antibody development. Cell Rep. 39, 110770 (2022).","journal-title":"Cell Rep."},{"key":"4923_CR4","doi-asserted-by":"publisher","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","volume":"35","author":"B Meng","year":"2021","unstructured":"Meng, B. et al. Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 35, 109292 (2021).","journal-title":"Cell Rep."},{"key":"4923_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"4923_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","volume":"602","author":"S Akatsuki","year":"2022","unstructured":"Akatsuki, S., Takashi, I., Rigel, S. & Tadashi, M. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 602, 300\u2013306 (2022).","journal-title":"Nature"},{"key":"4923_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(21)02844-0","volume":"399","author":"W Dejnirattisai","year":"2022","unstructured":"Dejnirattisai, W. et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet 399, 234\u2013236 (2022).","journal-title":"Lancet"},{"key":"4923_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437\u2013446 (2022).","journal-title":"Lancet"},{"key":"4923_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chom.2022.01.006","volume":"30","author":"A Escalera","year":"2022","unstructured":"Escalera, A. et al. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission. Cell Host Microbe 30, 373\u2013387.e7 (2022).","journal-title":"Cell Host Microbe"},{"key":"4923_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"4923_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"4923_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657\u2013663 (2022).","journal-title":"Nature"},{"key":"4923_CR13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"4923_CR14","doi-asserted-by":"publisher","first-page":"e0323821","DOI":"10.1128\/mbio.03238-21","volume":"13","author":"SB Park","year":"2022","unstructured":"Park, S. B. et al. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. MBio 13, e0323821 (2022).","journal-title":"MBio"},{"key":"4923_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","volume":"28","author":"JB Case","year":"2020","unstructured":"Case, J. B. et al. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe 28, 475\u2013485.e5 (2020).","journal-title":"Cell Host Microbe"},{"key":"4923_CR16","doi-asserted-by":"publisher","first-page":"32105","DOI":"10.1073\/pnas.2012197117","volume":"117","author":"R Zang","year":"2020","unstructured":"Zang, R. et al. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proc. Natl. Acad. Sci. USA 117, 32105\u201332113 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4923_CR17","doi-asserted-by":"publisher","unstructured":"Lamers, M. M., Mykytyn, A. Z., Breugem, T. I., Groen, N. & Knoops, K. SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium. bioRxiv https:\/\/doi.org\/10.1101\/2022.01.19.476898 (2022).","DOI":"10.1101\/2022.01.19.476898"},{"key":"4923_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-022-00422-1","volume":"8","author":"MC Chiu","year":"2022","unstructured":"Chiu, M. C. et al. A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant. Cell Discov. 8, 1\u201315 (2022).","journal-title":"Cell Discov."},{"key":"4923_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.2020106267","volume":"39","author":"J Buchrieser","year":"2020","unstructured":"Buchrieser, J. et al. Syncytia formation by SARS\u2010CoV\u20102\u2010infected cells. EMBO J. 39, 1\u201312 (2020).","journal-title":"EMBO J."},{"key":"4923_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","volume":"602","author":"A Saito","year":"2022","unstructured":"Saito, A. et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 602, 300\u2013306 (2022).","journal-title":"Nature"},{"key":"4923_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-021-00864-1","volume":"7","author":"X Du","year":"2022","unstructured":"Du, X. et al. Omicron adopts a different strategy from Delta and other variants to adapt to host. Signal Transduct. Target. Ther. 7, 5\u20137 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"4923_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.2021108944","volume":"40","author":"MM Rajah","year":"2021","unstructured":"Rajah, M. M. et al. SARS\u2010CoV\u20102 Alpha, Beta, and Delta variants display enhanced Spike\u2010mediated syncytia formation. EMBO J. 40, 1\u201317 (2021).","journal-title":"EMBO J."},{"key":"4923_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41594-020-0468-7","volume":"27","author":"AG Wrobel","year":"2020","unstructured":"Wrobel, A. G. et al. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat. Struct. Mol. Biol. 27, 763\u2013767 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"4923_CR24","doi-asserted-by":"publisher","first-page":"e0058721","DOI":"10.1128\/mBio.00587-21","volume":"12","author":"YW Cheng","year":"2021","unstructured":"Cheng, Y. W. et al. D614g substitution of sars-cov-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike cleavage. MBio 12, e0058721 (2021).","journal-title":"MBio"},{"key":"4923_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.abk2226","volume":"7","author":"SC Chiliveri","year":"2021","unstructured":"Chiliveri, S. C., Louis, J. M., Ghirlando, R. & Bax, A. Transient lipid-bound states of spike protein heptad repeats provide insights into SARS-CoV-2 membrane fusion. Sci. Adv. 7, 1\u201314 (2021).","journal-title":"Sci. Adv."},{"key":"4923_CR26","doi-asserted-by":"publisher","unstructured":"Englander, S. W., Downer, N. W. & Teitelbaum, H. Hydrogen exchange. Annu. Rev. Biochem. 903\u2013924. https:\/\/doi.org\/10.1038\/nsb0901-741 (1972).","DOI":"10.1038\/nsb0901-741"},{"key":"4923_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/prot.340170110","volume":"17","author":"Y Bai","year":"1993","unstructured":"Bai, Y., Milne, J. S., Mayne, L. & Englander, S. W. Primary structure effects on peptide group hydrogen exchange. Proteins Struct. Funct. Bioinforma. 17, 75\u201386 (1993).","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"4923_CR28","first-page":"1","volume":"119","author":"K Yang","year":"2022","unstructured":"Yang, K. et al. Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle. Proc. Natl. Acad. Sci. USA 119, 1\u20139 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4923_CR29","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/22221751.2020.1770631","volume":"9","author":"H Sun","year":"2020","unstructured":"Sun, H. et al. Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg. Microbes Infect. 9, 1238\u20131241 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"4923_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2209514119","volume":"119","author":"AJB Kreutzberger","year":"2022","unstructured":"Kreutzberger, A. J. B. et al. SARS-CoV-2 requires acidic pH to infect cells. Proc. Natl. Acad. Sci. USA 119, 1\u201312 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4923_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/pro.19","volume":"18","author":"GR Grimsley","year":"2009","unstructured":"Grimsley, G. R., Scholtz, J. M. & Pace, C. N. A summary of the measured pK values of the ionizable groups in folded proteins. Protein Sci. 18, 247\u2013251 (2009).","journal-title":"Protein Sci."},{"key":"4923_CR32","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abd4251","volume":"369","author":"Y Cai","year":"2020","unstructured":"Cai, Y. et al. Distinct conformational states of SARS-CoV-2 spike protein. Science (80-.). 369, 1586\u20131592 (2020).","journal-title":"Science (80-.)."},{"key":"4923_CR33","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N. & Bull, R. A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 32, e2381 (2022).","journal-title":"Rev. Med. Virol."},{"key":"4923_CR34","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/jmv.27643","volume":"94","author":"D Tian","year":"2022","unstructured":"Tian, D., Sun, Y., Xu, H. & Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. 94, 2376\u20132383 (2022).","journal-title":"J. Med. Virol."},{"key":"4923_CR35","doi-asserted-by":"publisher","unstructured":"Qu, P. et al. Distinct Neutralizing Antibody Escape of SARS-1 CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2. bioRxiv https:\/\/doi.org\/10.1101\/2022.10.19.512891 (2022).","DOI":"10.1101\/2022.10.19.512891"},{"key":"4923_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.chom.2022.07.006","volume":"30","author":"C Pastorio","year":"2022","unstructured":"Pastorio, C. et al. Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2. Cell Host Microbe 30, 1255\u20131268.e5 (2022).","journal-title":"Cell Host Microbe"},{"key":"4923_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"4923_CR38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-021-00715-z","volume":"7","author":"G B\u00e1lint","year":"2022","unstructured":"B\u00e1lint, G., V\u00f6r\u00f6s-Horv\u00e1th, B. & Sz\u00e9chenyi, A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct. Target. Ther. 7, 2\u20134 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"4923_CR39","doi-asserted-by":"publisher","first-page":"eabo7081","DOI":"10.1126\/scitranslmed.abo7081","volume":"14","author":"K Sun","year":"2022","unstructured":"Sun, K. et al. SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron\u2019s impact in South African population cohorts. Sci. Transl. Med. 14, eabo7081 (2022).","journal-title":"Sci. Transl. Med."},{"key":"4923_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2200592119","volume":"119","author":"AM Syed","year":"2022","unstructured":"Syed, A. M. et al. Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles. Proc. Natl. Acad. Sci. USA 119, 1\u20137 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4923_CR41","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"4923_CR42","doi-asserted-by":"publisher","first-page":"167280","DOI":"10.1016\/j.jmb.2021.167280","volume":"434","author":"MM Rajah","year":"2022","unstructured":"Rajah, M. M., Bernier, A., Buchrieser, J. & Schwartz, O. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. J. Mol. Biol. 434, 167280 (2022).","journal-title":"J. Mol. Biol."},{"key":"4923_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41421-021-00310-0","volume":"7","author":"H Ma","year":"2021","unstructured":"Ma, H. et al. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells. Cell Discov. 7, 7\u201310 (2021).","journal-title":"Cell Discov."},{"key":"4923_CR44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-021-00715-z","volume":"7","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann, M., Zhang, L. & P\u00f6hlmann, S. Omicron: Master of immune evasion maintains robust ACE2 binding. Signal Transduct. Target. Ther. 7, 2\u20134 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"4923_CR45","doi-asserted-by":"publisher","first-page":"105720","DOI":"10.1016\/j.isci.2022.105720","volume":"25","author":"I Kimura","year":"2022","unstructured":"Kimura, I. et al. The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant. iScience 25, 105720 (2022).","journal-title":"iScience"},{"key":"4923_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-022-00325-x","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y. Biol. Direct 17, 1\u201311 (2022).","journal-title":"Biol. Direct"},{"key":"4923_CR47","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber, B. et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell 182, 812\u2013827.e19 (2020).","journal-title":"Cell"},{"key":"4923_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21118-2","volume":"12","author":"S Ozono","year":"2021","unstructured":"Ozono, S. et al. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nat. Commun. 12, 848 (2021).","journal-title":"Nat. Commun."},{"key":"4923_CR49","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell 182, 1295\u20131310.e20 (2020).","journal-title":"Cell"},{"key":"4923_CR50","doi-asserted-by":"publisher","unstructured":"Dacon, C. et al. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe 1\u201315. https:\/\/doi.org\/10.1016\/j.chom.2022.10.010 (2022).","DOI":"10.1016\/j.chom.2022.10.010"},{"key":"4923_CR51","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.abq3773","volume":"377","author":"C Dacon","year":"2022","unstructured":"Dacon, C. et al. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science (80-.). 377, 728\u2013735 (2022).","journal-title":"Science (80-.)."},{"key":"4923_CR52","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1128\/JVI.00797-10","volume":"84","author":"X Sun","year":"2010","unstructured":"Sun, X., Tse, L. V., Ferguson, A. D. & Whittaker, G. R. Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus. J. Virol. 84, 8683\u20138690 (2010).","journal-title":"J. Virol."},{"key":"4923_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-020-00222-5","volume":"6","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. Cell Discov. 6, 80 (2020).","journal-title":"Cell Discov."},{"key":"4923_CR54","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1126\/science.abj8430","volume":"374","author":"I Ricardo-Lax","year":"2021","unstructured":"Ricardo-Lax, I. et al. Replication and single-cycle delivery of SARS-CoV-2 replicons. Science. 374, 1099\u20131106 (2021).","journal-title":"Science."},{"key":"4923_CR55","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1080\/22221751.2020.1815589","volume":"9","author":"HL Xiong","year":"2020","unstructured":"Xiong, H. L. et al. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells. Emerg. Microbes Infect. 9, 2105\u20132113 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"4923_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1261\/rna.2192803","volume":"9","author":"SA Stewart","year":"2003","unstructured":"Stewart, S. A. et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. Rna 9, 493\u2013501 (2003).","journal-title":"Rna"},{"key":"4923_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041695","volume":"22","author":"BO Villoutreix","year":"2021","unstructured":"Villoutreix, B. O., Calvez, V., Marcelin, A. G. & Khatib, A. M. In silico investigation of the new UK (B.1.1.7) and South African (501y.v2) SARS-CoV-2 variants with a focus at the ace2\u2013spike rbd interface. Int. J. Mol. Sci. 22, 1\u201313 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"4923_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas, D. et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 596, 276\u2013280 (2021).","journal-title":"Nature"},{"key":"4923_CR59","doi-asserted-by":"publisher","unstructured":"Tscherne, D. M. & Garc\u00eda-Sastre, A. An enzymatic assay for detection of viral entry. Curr. Protoc. Cell Biol. https:\/\/doi.org\/10.1002\/0471143030.cb2612s51 (2011).","DOI":"10.1002\/0471143030.cb2612s51"},{"key":"4923_CR60","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0006-3495(01)75864-X","volume":"81","author":"KJ Glover","year":"2001","unstructured":"Glover, K. J. et al. Structural evaluation of phospholipid bicelles for solution-state studies of membrane-associated biomolecules. Biophys. J. 81, 2163\u20132171 (2001).","journal-title":"Biophys. J."},{"key":"4923_CR61","doi-asserted-by":"publisher","first-page":"8453","DOI":"10.1021\/bi060615u","volume":"45","author":"RS Prosser","year":"2006","unstructured":"Prosser, R. S., Evanics, F., Kitevski, J. L. & Al-Abdul-Wahid, M. S. Current applications of bicelles in NMR studies of membrane-associated amphiphiles and proteins. Biochemistry 45, 8453\u20138465 (2006).","journal-title":"Biochemistry"},{"key":"4923_CR62","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/pro.701","volume":"20","author":"NC Fitzkee","year":"2011","unstructured":"Fitzkee, N. C., Torchia, D. A. & Bax, A. Measuring rapid hydrogen exchange in the homodimeric 36 kDa HIV-1 integrase catalytic core domain (Protein Science (2011) 20, (500-512)). Protein Sci. 20, 1643 (2011).","journal-title":"Protein Sci."},{"key":"4923_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10858-008-9234-6","volume":"41","author":"OK Baryshnikova","year":"2008","unstructured":"Baryshnikova, O. K., Williams, T. C. & Sykes, B. D. Internal pH indicators for biomolecular NMR. J. Biomol. NMR 41, 5\u20137 (2008).","journal-title":"J. Biomol. NMR"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04923-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04923-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04923-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T17:12:44Z","timestamp":1702487564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04923-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4923"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-04923-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"556"}}